According to a current publication of the European Centre for Prevention and Control of Diseases (ECDC), this year’s total number of cases exceeds the total number of West Nile fever (WNF) cases in Europe of the past five years by far. WNV belongs to the most widely distributed flaviviruses. West Nile fever (WNF), caused by […]
Over the past years, a global spread of a multitude of new viruses and other pathogens has been observed, leading to previously unknown diseases. Lately, there was an increase in epidemics of vector-borne infectious diseases, especially in tropical regions. Alongside dengue and chikungunya fever, Zika fever, which spread in large parts of the South American
In its recent epidemiological bulletin (no. 15) the German Robert Koch Institute reports about exceedingly high numbers of hantavirus infections in Germany. In total, 1,713 cases had been registered in 2017 – in the previous year, there were only 298. Indeed, the number of infections fluctuates considerably from year to year. Also 2007, 2010 and 2012 were
Previous year, EUROIMMUN launched the Anti-Zika Virus ELISA IgA. It had turned out that specific anti-Zika virus IgA antibodies against the non-structural protein 1 (NS1) could serve as alternative indicators of acute infection phase if specific IgM antibodies were not detectable. Particularly when patients, who already have had a first contact with a flavivirus (infection
Measles and mumps, two forgotten diseases, reveal an unfortunate comeback. In a free webinar on February 15th, Oliver Sendscheid, PhD, Scientific Director at EUROIMMUN US, and Rolando Pajon, PhD, Lead Scientist for Vaccine and Novel Immunotherapeutic Laboratory Solutions at COVANCE CLS addressed the current epidemiologic status of measles and mumps, challenges and solutions in serological testing,
